In gastrointestinal cancers, diagnostic biomarkers such as SALL4 and Glypican 3 are used to identify "gastric adenocarcinoma or CRAC with enteroblastic differentiation (GAED or CRAED)," but JIAED has not been reported previously. Here, SALL4 is linked to gastric adenocarcinoma.